SELLAS Life Sciences Group, Inc. (SLS) Price
SELLAS Life Sciences Group, Inc.
SLS
Dados de mercado indisponíveis.
Volume (24h)
--
Oferta em circulação
--
Capitalização de mercado
--
Sobre a SELLAS Life Sciences Group, Inc. (SLS)
Sobre a SELLAS Life Sciences Group, Inc. (SLS)
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company focused on developing novel cancer immunotherapies. Its lead asset, galinpepimut-S, targets a range of cancers including acute myeloid leukemia and mesothelioma. SELLAS operates in a highly specialized field with strong scientific backing and multiple ongoing trials. It aims to deliver targeted, life-extending treatments to patients with unmet medical needs.
Baixar o
Aplicativo móvel Gemini
Indique amigos e ganhe criptomoedas.
Convide amigos para a Gemini, e vocês dois ganharão US$ 50 em criptomoedas quando sua indicação negociar US$ 100 nos primeiros 30 dias.
Tokens mais procurados
Tokens mais procurados
Gemini ActiveTrader®
Negocie SELLAS Life Sciences Group, Inc. na plataforma projetada e desenvolvida para traders
Tokens mais procurados
Tokens mais procurados
Sobre a SELLAS Life Sciences Group, Inc. (SLS)
Sobre a SELLAS Life Sciences Group, Inc. (SLS)
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company focused on developing novel cancer immunotherapies. Its lead asset, galinpepimut-S, targets a range of cancers including acute myeloid leukemia and mesothelioma. SELLAS operates in a highly specialized field with strong scientific backing and multiple ongoing trials. It aims to deliver targeted, life-extending treatments to patients with unmet medical needs.